8716 Results
1

WVXU: Meet the UC doctor trying to change minds skeptical of the COVID-19 vaccine

December 29, 2020

Louito Edje, MD, associate dean of graduate medical education at the University of Cincinnati College of Medicine and UC Medical Center, spoke with WVXU about why she is on a public relations blitz – participating in segments on CNBC, TMZ, BET and MSNBC - to change minds about vaccinations for COVID-19. The pandemic is having a disproportionate impact on Black Americans and Edje, a Black female physician, is hoping her participation in the Moderna vaccine trial and her voice may sway some opinions about vaccine safety and efficacy.

3

Texas Public Radio: Is COVID-19 A Vascular Disease?

July 2, 2020

COVID-19 appears to be a multi-system inflammatory disease. It may begin in the lungs but is escaping to other parts of the body. Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, shares his knowledge about COVID-19 and the cardiovascular system with Texas Public Radio.

6

WVXU: COVID-19 may attack a patient’s central nervous system

August 21, 2020

Ahmad Sedaghat, director of rhinology, allergy and anterior skull base surgery at the University of Cincinnati, discusses COVID-19 attack on the central nervous system with NPR affiliate in Cincinnati WVXU. Sedaghat, an assistant professor in the College of Medicine, sees patients at UC Health where he specializes in diseases of the nose and sinuses.

7

Fox 19: UC doctor part of team developing new COVID-19 antibody test

August 20, 2020

Steve Woodle, MD, William A. Altemeier Chair in Research Surgery at the UC College of Medicine, spoke to a Fox 19 journalist about his latest research. He is part of a national team working on a new test that can determine the effectiveness of antibodies against COVID-19 and also does a better job of reducing false positives in detecting the novel coronavirus.

8

Fox 19: UC Health psychologist talks back-to-school discussions, mask wearing

August 19, 2020

Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neurosciences at the UC College of Medicine, offers advice for parents wishing to talk to their children about staying safe in the midst of COVID-19. Schools are reopening and parents are anxious as the pandemic continues.

9

Contagion Live: Targeting Lung Blood Vessel Inflammation in COVID-19 Patients

September 30, 2020

Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed by a reporter for Contagion Live about a new phase 2 clinical trial UC and UC Health are conducting using the drug razuprotafib, to lessen inflammation of the blood vessels in COVID-19 patients. Razuprotafib activates a key pathway for stabilizing blood vessels in the lungs and may prevent or treat respiratory distress in COVID-19 patients.